This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Dec 15;102(24):1815-7.

doi: 10.1093/jnci/djq466. Epub 2010 Nov 29.

Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?

Frank L Meyskens Jr, Christine E McLaren

PMID: 21115881
DOI: 10.1093/jnci/djq466

Editorial

Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?

Frank L Meyskens Jr et al. J Natl Cancer Inst. 2010.

. 2010 Dec 15;102(24):1815-7.

doi: 10.1093/jnci/djq466. Epub 2010 Nov 29.

Authors

Frank L Meyskens Jr, Christine E McLaren

PMID: 21115881
DOI: 10.1093/jnci/djq466

No abstract available

PubMed Disclaimer

Comment on

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB. Elmets CA, et al. J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29. J Natl Cancer Inst. 2010. PMID: 21115882 Free PMC article. Clinical Trial.

Similar articles

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB. Elmets CA, et al. J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29. J Natl Cancer Inst. 2010. PMID: 21115882 Free PMC article. Clinical Trial.
Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
Liebman TN, Stein JA, Polsky D. Liebman TN, et al. J Am Acad Dermatol. 2013 Jan;68(1):173-6. doi: 10.1016/j.jaad.2012.06.037. J Am Acad Dermatol. 2013. PMID: 23244374 No abstract available.
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.
Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET; Adenoma Prevention with Celecoxib Study Investigators. Bertagnolli MM, et al. Cancer Prev Res (Phila). 2009 Apr;2(4):310-21. doi: 10.1158/1940-6207.CAPR-08-0206. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336730 Free PMC article. Clinical Trial.
Chemoprevention of cancer.
Tsao AS, Kim ES, Hong WK. Tsao AS, et al. CA Cancer J Clin. 2004 May-Jun;54(3):150-80. doi: 10.3322/canjclin.54.3.150. CA Cancer J Clin. 2004. PMID: 15195789 Review.
Nicotinamide: New Indications in Dermatology.
Escudero-Góngora MM, Fernández-Peñas P. Escudero-Góngora MM, et al. Actas Dermosifiliogr. 2016 Nov;107(9):777-778. doi: 10.1016/j.ad.2016.05.015. Epub 2016 Jul 1. Actas Dermosifiliogr. 2016. PMID: 27377936 Review. English, Spanish. No abstract available.

See all similar articles

Cited by

Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy.
Weicht RR, Schultz CR, Geerts D, Uhl KL, Bachmann AS. Weicht RR, et al. Med Sci (Basel). 2018 Aug 16;6(3):65. doi: 10.3390/medsci6030065. Med Sci (Basel). 2018. PMID: 30115881 Free PMC article.
Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.
Yoo SS, Jorgensen TJ, Kennedy AR, Boice JD Jr, Shapiro A, Hu TC, Moyer BR, Grace MB, Kelloff GJ, Fenech M, Prasanna PG, Coleman CN. Yoo SS, et al. J Radiol Prot. 2014 Jun;34(2):R25-52. doi: 10.1088/0952-4746/34/2/R25. Epub 2014 Apr 14. J Radiol Prot. 2014. PMID: 24727460 Free PMC article. Review.
Controlled-release systemic delivery - a new concept in cancer chemoprevention.
Gupta RC, Bansal SS, Aqil F, Jeyabalan J, Cao P, Kausar H, Russell GK, Munagala R, Ravoori S, Vadhanam MV. Gupta RC, et al. Carcinogenesis. 2012 Aug;33(8):1608-15. doi: 10.1093/carcin/bgs209. Epub 2012 Jun 13. Carcinogenesis. 2012. PMID: 22696595 Free PMC article.
Advanced drug delivery systems of curcumin for cancer chemoprevention.
Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC. Bansal SS, et al. Cancer Prev Res (Phila). 2011 Aug;4(8):1158-71. doi: 10.1158/1940-6207.CAPR-10-0006. Epub 2011 May 5. Cancer Prev Res (Phila). 2011. PMID: 21546540 Free PMC article. Review.
Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach.
Meyskens FL Jr, Gerner EW. Meyskens FL Jr, et al. Cancer Prev Res (Phila). 2011 May;4(5):628-32. doi: 10.1158/1940-6207.CAPR-11-0162. Cancer Prev Res (Phila). 2011. PMID: 21543341 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

P30 CA062203/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems